Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash from Operations: 2009-2024

Historic Cash from Operations for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $120.1 million.

  • Cross Country Healthcare's Cash from Operations rose 16926.37% to $20.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.7 million, marking a year-over-year decrease of 6497.01%. This contributed to the annual value of $120.1 million for FY2024, which is 5166.32% down from last year.
  • Per Cross Country Healthcare's latest filing, its Cash from Operations stood at $120.1 million for FY2024, which was down 5166.32% from $248.5 million recorded in FY2023.
  • Over the past 5 years, Cross Country Healthcare's Cash from Operations peaked at $248.5 million during FY2023, and registered a low of -$85.6 million during FY2021.
  • For the 5-year period, Cross Country Healthcare's Cash from Operations averaged around $88.8 million, with its median value being $120.1 million (2024).
  • In the last 5 years, Cross Country Healthcare's Cash from Operations skyrocketed by 39086.97% in 2020 and then plummeted by 41472.58% in 2021.
  • Cross Country Healthcare's Cash from Operations (Annual) stood at $27.2 million in 2020, then plummeted by 414.73% to -$85.6 million in 2021, then surged by 256.57% to $134.0 million in 2022, then surged by 85.38% to $248.5 million in 2023, then plummeted by 51.66% to $120.1 million in 2024.
  • Its Cash from Operations stands at $120.1 million for FY2024, versus $248.5 million for FY2023 and $134.0 million for FY2022.